Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients
dc.contributor.author | Quintanilha, Julia C.F. | |
dc.contributor.author | Wang, Jin | |
dc.contributor.author | Sibley, Alexander B. | |
dc.contributor.author | Jiang, Chen | |
dc.contributor.author | Etheridge, Amy S. | |
dc.contributor.author | Shen, Fei | |
dc.contributor.author | Jiang, Guanglong | |
dc.contributor.author | Mulkey, Flora | |
dc.contributor.author | Patel, Jai N. | |
dc.contributor.author | Hertz, Daniel L. | |
dc.contributor.author | Dees, Elizabeth Claire | |
dc.contributor.author | McLeod, Howard L. | |
dc.contributor.author | Bertagnolli, Monica | |
dc.contributor.author | Rugo, Hope | |
dc.contributor.author | Kindler, Hedy L. | |
dc.contributor.author | Kelly, William Kevin | |
dc.contributor.author | Ratain, Mark J. | |
dc.contributor.author | Kroetz, Deanna L. | |
dc.contributor.author | Owzar, Kouros | |
dc.contributor.author | Schneider, Bryan P. | |
dc.contributor.author | Lin, Danyu | |
dc.contributor.author | Innocenti, Federico | |
dc.contributor.department | Medicine, School of Medicine | en_US |
dc.date.accessioned | 2023-05-15T12:30:43Z | |
dc.date.available | 2023-05-15T12:30:43Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Correction to: British Journal of Cancer 10.1038/s41416-021-01557-w, published online 06 October 2021 The original version of this article unfortunately contained a mistake in an author affiliation. Dr. Kouros Owzar was listed as “Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA”, when it should be “Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA”. The original article has been corrected. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Quintanilha JCF, Wang J, Sibley AB, et al. Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients. Br J Cancer. 2022;126(1):162. doi:10.1038/s41416-021-01617-1 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/32960 | |
dc.language.iso | en_US | en_US |
dc.publisher | Springer Nature | en_US |
dc.relation.isversionof | 10.1038/s41416-021-01617-1 | en_US |
dc.relation.journal | British Journal of Cancer | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Cancer genetics | en_US |
dc.subject | Predictive markers | en_US |
dc.title | Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients | en_US |
dc.type | Article | en_US |
ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727676/ | en_US |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- 41416_2021_Article_1617.pdf
- Size:
- 175.93 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.99 KB
- Format:
- Item-specific license agreed upon to submission
- Description: